Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available)

Product description

Voriconazole 200 mg/Vial Powder for Solution for Infusion
Reference Product: Vfend® / Pfizer
Description: In the treatment of the following fungal infections: Invasive aspergillosis, Candidemia, Esophageal candidiasis, Serious fungal infections caused by Scedosporium apiospermum (asexual form of Pseudallescheria boydii) and Fusarium spp. including Fusarium solani, in patients intolerant of, or refractory to, other therapy.
Dossier Status: EU CTD Available
Stability Studies: Zone II / Zone IVb
Shelf life: Three (3) years
Batch Sizes: 12,000 vials
Pack Sizes: BT x 1 vial
Read more

Specifications

Categories Finished Dosage FormsInjectables; Contract Services - Contract ServicesLyophilisation; Finished Dosage FormsOut-licensing
Sales markets Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central/South America
Supplied from Greece
Selling Points International Approvals/Standards

More products from ANFARM HELLAS S.A.

View all our products (29)

Products from other suppliers